TD Cowen Reiterates Buy on Boston Scientific, Maintains $56 Price Target
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsReiterationPrice TargetHot
TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $56 price target.
TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $56 price target.